Kim DDH, Kim TS, Atenafu EG, Novitzky Basso I, et al. BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase. Br J Haematol 2022;196:136-145.
PMID: 34496035